What companies are PBYI's competitors?

Puma Biotechnology, Inc. (PBYI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does PBYI compare to its peers?

The peer comparison table on this page shows Puma Biotechnology, Inc. (PBYI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does PBYI operate in?

Puma Biotechnology, Inc. (PBYI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PBYI

Puma Biotechnology, Inc.

NASDAQ·Biotechnology · Healthcare

$7.87$0.71−8.28%

Pre-market·$9.00+14.36%

Market cap$400.58M·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About PBYI

What companies are PBYI's competitors?: Puma Biotechnology, Inc. (PBYI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PBYI compare to its peers?: The peer comparison table on this page shows Puma Biotechnology, Inc. (PBYI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PBYI operate in?: Puma Biotechnology, Inc. (PBYI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

PBYI

Puma Biotechnology, Inc.

NASDAQ·Biotechnology · Healthcare

$7.87$0.71−8.28%

Pre-market·$9.00+14.36%

Market cap$400.58M·Market closed·Jul 22 8:00 PM UTC

Peers


ALLO	Allogene Therapeutics, Inc.	$1.86	$453.6M
AVIR	Atea Pharmaceuticals, Inc.	$4.81	$384.9M
ABEO	Abeona Therapeutics Inc.	$6.42	$365.9M
TRDA	Entrada Therapeutics, Inc.	$6.15	$238.7M
SGMT	Sagimet Biosciences Inc.	$7.05	$229.7M
ELDN	Eledon Pharmaceuticals, Inc.	$3.72	$223.0M
VYGR	Voyager Therapeutics, Inc.	$3.10	$187.3M
ARCT	Arcturus Therapeutics Holdings Inc.	$5.93	$168.5M
HUMA	Humacyte, Inc.	$0.64	$108.3M

Frequently Asked Questions About PBYI

What companies are PBYI's competitors?: Puma Biotechnology, Inc. (PBYI)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does PBYI compare to its peers?: The peer comparison table on this page shows Puma Biotechnology, Inc. (PBYI) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does PBYI operate in?: Puma Biotechnology, Inc. (PBYI) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.